Publications 2023
Les publications du GRPso / 2023
Skrek S, Di Lernia V, Beauchet A, Bursztejn AC, Belloni Fortina A, Lesiak A, Thomas J, Brzezinski P, Topkarci Z, Murashkin N, Torres T, Epishev R, Chiriac A, McPherson T, Akinde M, Maruani A, Luna PC, Vidaurri de la Cruz H, Mallet S, Leducq S, Sergeant M, Zitouni J, Mahil SK, Smith CH, Flohr C, Bachelez H, Mahé E, and the Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology, and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.). Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection. J Eur Acad Dermatol Venereol. 2023 Jun 16. doi: 10.1111/jdv.19261. Online ahead of print
Hanafi B, Beauchet A, Di Lernia V, Lasek A, Severino-Freire M, Barbarot S, Hadj-Rabia S, Phan A, Bursztejn AC, Maruani A, Chaby G, Quiles-Tsimaratos N, Phan C, Zitouni J, Mazereeuw-Hautier J, Mahé E, and Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie (SFD), Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), and Società Italiana di Dermatologia Pediatrica (S.I.Der.P.). Effectiveness of biologic therapies in children with palmoplantar plaque psoriasis: an analysis of real-life data from the BiPe cohorts. Pediatr Dermatol 2023 in press
Koren J, Lambert JLW, Thomsen SF, McAteer H, Fabbrocini G, Corazza V, Jullien D, Augustin M, Warren RB, de Rie MA, Lazaridou E, Puig L, Guillevin L, Grosser M, Boehncke WH. Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative. Dermatol Ther (Heidelb). 2022 Dec 9. doi: 10.1007/s13555-022-00846-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734585/
Guillo L, Flachaire B, Avouac J, Dong C, Nachury M, Bouguen G, Buisson A, Caillo L, Fumery M, Gilletta C, Hébuterne X, Lafforgue P, Laharie D, Mahé E, Marotte H, Nancey S, Ottaviani S, Salmon JH, Savoye G, Serrero M, Uzzan M, Viguier M, Richez C, Peyrin-Biroulet L, Seksik P, Pham T; COMBIO Study Group. Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. Dig Liver Dis. 2023 Jan;55(1):61-68. doi: 10.1016/j.dld.2022.07.012.
Bettuzzi T, Bachelez H, Beylot-Barry M, Arlégui H, Paul C, Viguier M, Mahé E, Beneton N, Jullien D, Richard MA, Joly P, Tubach F, Dupuy A, Sbidian E, Chosidow O; PsoBioTeq study group. Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort. Acta Derm Venereol. 2022 Mar 8;102:adv00665. doi: 10.2340/actadv.v101.566. PMID: 34806759; PMCID: PMC9631244.
Curmin R, Guillo S, De Rycke Y, Bachelez H, Beylot-Barry M, Beneton N, Chosidow O, Dupuy A, Joly P, Jullien D, Richard MA, Viguier M, Sbidian E, Paul C, Mahé E, Tubach F; PSOBIOTEQ Study Group. Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2101-2112. doi: 10.1111/jdv.18409. Epub 2022 Jul 22. PMID: 35793473; PMCID: PMC9796114.
Aubert H, Arlegui H, De Rycke Y, Bachelez H, Beylot-Barry M, Dupuy A, Joly P, Jullien D, Mahé E, Paul C, Richard MA, Sbidian E, Viguier M, Chosidow O, Tubach F, Bénéton N; PsoBioTeq Study Group. Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry. Br J Dermatol. 2023 Jan 23;188(1):150-152. doi: 10.1093/bjd/ljac024. PMID: 36689510.
Salle R, Tubach F, Arlegui H, Curmin R, Viguier M, Beylot-Barry M, Dupuy A, Beneton N, Joly P, De Rycke Y, Jullien D, Mahé E, Paul C, Richard MA, Bachelez H, Zago M, Chosidow O, Sbidian E, PsioBioTeq. Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohort. Clin Exp Dermatol, 2023 Jul 6; llad233, https://doi.org/10.1093/ced/llad233
Arlequi H, Mahé E, Richard MA, De Rycke Y, Viguier M, Beylot-Barry M, Dupuy A, Beneton N, Joly P, Jullien D, Bachelez H, Sbidian E, Chosidow O, Paul C, Tubach F, PsoBioTeq study group. Impact of the first wave of the COVIC-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort. Ann Dermatol Venereol 2023 Jun;150(2):101-108. doi: 10.1016/j.annder.2023.01.005. Epub 2023 Feb 15.
Mahé E, Tubach F, Jullien D, Tran D, Paul C, Beylot-Barry M, Dupuy A, Viguier M, Richard MA, Sbidian E, Beneton N, Joly P, Chosidow O, Bachelez H; PSOBIOTEQ Registry investigators. Impact of Childhood Onset Psoriasis on Addictive Behaviours, Socioeconomic and Educational Data in Adulthood. Acta Derm Venereol. 2022 Jun 9;102:adv00733. doi: 10.2340/actadv.v102.2484. PMID: 35506359; PMCID: PMC9593492.
El Mahi Y, Varin A, Vetter M, Dal Zuffo L, Mazzeo L, Pais De Barros JP, Aubin F, Saas P, Gallais Sérézal I. Resolved Psoriasis with Abundant Oleic Acid in Stratum Corneum Exhibits Lower T-Cell-Driven IL-17 Signature. J Invest Dermatol, 2023 May 18;S0022-202X(23)02067-5. doi: 10.1016/j.jid.2023.04.021. Online ahead of print.
Caël B, Bôle-Richard E, Galaine J, Adotevi O, Garnache-Ottou F, Aubin F. Production of functional plasmacytoid dendritic cells - targeted chimeric antigen receptor T cells from patients with immune-mediated inflammatory diseases. Br J Dermatol, 2023 Jul 17;189(2):234-236. doi: 10.1093/bjd/ljad105.